ZURICH, Aug 16 (Reuters) - Swiss medical device maker Synthes (SYST.VX: Quote, Profile, Research) got the green light from the U.S. Food and Drug Administration to market its ProDisc-L replacement spinal disc, which is implanted to replace a diseased or damaged disc.
